Riboflavin — Clinical Overview
| Indication | Form | Dose | Duration | Notes |
|---|---|---|---|---|
| Deficiency (mild) | Oral riboflavin | 5–10 mg/day | 6 weeks | Divided doses; absorption saturates at ~25 mg |
| Ariboflavinosis (severe) | Oral / IV | 10–30 mg/day divided | Until recovery | Angular stomatitis, magenta glossitis, cheilosis |
| Migraine prophylaxis | Oral riboflavin | 400 mg once daily | ≥3 months | Grade B evidence; improves mitochondrial metabolism |
| Pregnancy RDA | Oral | 1.4 mg/day | Throughout | Lactation requirement: 1.6 mg/day |
| Neonatal phototherapy | Oral / IV | 0.1–0.3 mg/kg/day | During light exposure | Phototherapy photodegrades circulating riboflavin |
Absorption & Pharmacokinetics
Riboflavin absorption occurs in the proximal small intestine via an active, carrier-mediated transport mechanism that becomes saturated at approximately 25–27 mg in a single dose. Single mega-doses above this threshold are largely eliminated unchanged in the urine. When higher daily doses are required for therapeutic repletion, divide the total dose across 2 to 3 administrations with meals.
Migraine Prophylaxis Rationale
The 400 mg/day oral dosage used in migraine prophylaxis works by enhancing mitochondrial electron transport chain efficiency and overcoming cellular energy deficits implicated in migraine pathophysiology. Advise patients that therapeutic reduction in migraine frequency usually requires 4 to 12 weeks of continuous prophylaxis.